Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06400862
PHASE1
Treating Patients With Traumatic Chondral Lesions With Autologous Bone Marrow Cells Derived Engineered Tissues - Engineered Osteochondral Tissue
Sponsor: Chinese University of Hong Kong
View on ClinicalTrials.gov
Summary
The objective of the study is to establish the safety profile of the autologous engineered osteochondral tissues (eOCT) in treating traumatic chondral lesions in patients.
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
9
Start Date
2024-02-26
Completion Date
2026-12-31
Last Updated
2024-05-06
Healthy Volunteers
No
Conditions
Interventions
COMBINATION_PRODUCT
eOCT implantation
eOCT is regarded as an Advanced Therapy Product (ATP).
Locations (2)
Queen Elizabeth Hospital
Jordon, Hong Kong
Prince of Wales Hospital
Shatin, Hong Kong